Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells

BACKGROUND: Regulatory B cells are a newly discovered B cell subset that suppresses immune responses. Recent studies found that both anti-CD45RB and anti–Tim-1 treatments regulate immune responses by inducing regulatory B cells; however, the role of these cells in renal ischemia-reperfusion injury (...

詳細記述

保存先:
書誌詳細
出版年:J Am Soc Nephrol
主要な著者: Fang, Taishi, Koo, Tai Yeon, Lee, Jae-Ghi, Jang, Joon Young, Xu, Yixuan, Hwang, Ju Hee, Park, Sunjoo, Yan, Ji-Jing, Ryu, Jung-Hwa, Ryu, Yeon-Mi, Kim, Sang-Yeob, Suh, Kyung-Suk, Yang, Jaeseok
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Nephrology 2019
主題:
Basic Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779371/
https://ncbi.nlm.nih.gov/pubmed/31296607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101067
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料